MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Assessment of Quality of Life in Patients with Hemifacial Spasm: Preliminary Report of a Case-Control Study

N. Durmaz Celik, N. Garipcin, E. Tatlı, M. Kuzu Kumcu, S. Ozkan (Eskisehir, Turkey)

Meeting: 2025 International Congress

Keywords: Anxiety, Hemifacial spasm(HFS), Pittsburgh Sleep Quality Index(PSQI)

Category: Non-Dystonia (Other)

Objective: This study aims to assess the impact of HFS on quality of life by comparing physical, psychological, social, and environmental well-being between HFS patients and healthy controls. Additionally, it seeks to explore trends in depression, anxiety, and sleep disturbances in HFS patients.

Background: Hemifacial spasm (HFS) is an uncommon movement disorder defined by involuntary contractions of facial muscles on one side of the face. It has a significant impact on patients’ quality of life. HFS is not only physically uncomfortable but can also cause social, psychological, and emotional distress, often leading to depression, anxiety, and sleep disturbances. Because the quality-of-life implications of HFS remain largely uninvestigated, the objective of this study was to characterize the psychosocial burden of this condition, as well as comorbidities associated with its development.

Method: This case-control study included 18 patients diagnosed with HFS and 17 age- and sex-matched healthy controls. Participants completed validated questionnaires assessing depression, anxiety, sleep quality, and health-related quality of life across physical, psychological, social, and environmental domains. Data were analyzed using the Mann-Whitney U, Fisher’s exact, and Chi-square tests.

Results: Although statistical significance was not reached, an interesting trend was observed towards more significant depressive symptoms and poor sleep quality in HFS patients than controls (p=0.407). Psychological well-being was worse in the HFS group with moderate to severe psychological distress (38.9% vs. 29.4%). While self-reported social and environmental quality-of-life measures also trended toward worsening in HFS patients, differences were not statistically significant.

Conclusion: These early results indicate that HFS may affect psychological status and daily activity. Although the differences were not statistically significant, the observed trends suggest that more extensive studies are needed to validate these associations. It still requires a multidisciplinary approach for the overall improvement of the patient by integrating neurological and psychosocial aid.

To cite this abstract in AMA style:

N. Durmaz Celik, N. Garipcin, E. Tatlı, M. Kuzu Kumcu, S. Ozkan. Assessment of Quality of Life in Patients with Hemifacial Spasm: Preliminary Report of a Case-Control Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/assessment-of-quality-of-life-in-patients-with-hemifacial-spasm-preliminary-report-of-a-case-control-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/assessment-of-quality-of-life-in-patients-with-hemifacial-spasm-preliminary-report-of-a-case-control-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley